Baltimore-based Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Washington, D.C.-based Howard University Cancer Center are "reigniting" their established partnership to eliminate health disparities in the Washington, D.C., area.
The Latest
Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a promising tool to predict which patients will respond well to…
Fred Hutchinson and three other cancer centers are creating a comprehensive AI model without compromising patient confidentiality.
A topical immunotherapy drug can effectively eliminate precancerous spots, preventing squamous cell carcinoma occurrence, according to a study published Jan. 2 in the Journal of Clinical Investigation.
Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.
The Grand Rapids, Mich.-based Van Andel Institute has developed a new free and publicly available resource for identifying and classifying cancer subtypes.
Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature.
Cleveland Clinic submitted plans to the city for approval of a $200 million Fairview Hospital expansion project, including the addition of a new, nearly 170,000-square-foot cancer center, according to a Dec. 12 News 5 Cleveland report.
Pittsburgh-based Allegheny Health Network has transitioned radiation therapy services out of the Greensburg, Pa.-based AHN Cancer Institute—Hempfield.
What remains after the passing of former President Jimmy Carter encompasses more than politics and humanitarianism, it also includes cancer care, according to a Dec. 29 NBC News report.